机构：[1]Shandong Cancer Hospital, Jinan, China[2]The First Affiliated Hospital of Air Force Military Medical University, Xi’an, China[3]Shandong Cancer Hospital and Institute, Jinan, China[4]Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China[5]Affiliated Hospital of Yangzhou University, Yangzhou, China[6]Taixing People’s Hospital, Taixing, China[7]Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院[8]Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[9]Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China[10]Affiliated Hospital of Xuzhou Medical University, Xuzhou, China[11]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属协和医院[12]Peking University Shenzhen Hospital, Shenzhen, China北京大学深圳医院深圳医学信息中心[13]Weihai Municipal Hospital, Weihai Shandong Province, China[14]Affiliated Hospital of Shandong First Medical University, Jinan, China
Xing Ligang,Zhao Lina,Li Dapeng,et al.Efficacy and safety of mecapegfilgrastim in preventing neutropenia during concurrent chemoradiotherapy[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA：
Xing, Ligang,Zhao, Lina,Li, Dapeng,Yang, Zhe,Chen, Yong...&Yu, Jinming.(2024).Efficacy and safety of mecapegfilgrastim in preventing neutropenia during concurrent chemoradiotherapy.JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA：
Xing, Ligang,et al."Efficacy and safety of mecapegfilgrastim in preventing neutropenia during concurrent chemoradiotherapy".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)
医学